| Literature DB >> 33535832 |
Yan Wang1, Jun Wei1, Guoli Liu1, Yani Yan1, Zhenjuan Yang1, Yuntao Li1, Qiuyan Pei1.
Abstract
OBJECTIVE: To assess the effect of regular third-trimester ultrasound on antenatal detection and perinatal outcomes of small for gestational age (SGA) infants.Entities:
Keywords: Fetal growth restriction; small for gestational age; ultrasonography
Mesh:
Year: 2021 PMID: 33535832 PMCID: PMC7871070 DOI: 10.1177/0300060521989204
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Variables used as potential confounders in 407 pregnancies resulting in SGA infants.
| Variable | SGA + FGR | SGA–FGR | Statistical significance |
|---|---|---|---|
| Total, | 268 (65.85) | 139 (34.15) | |
| Maternal | |||
| Age, years | 31.22 ± 4.50 | 31.39 ± 4.03 | NS |
| Parity | 1.23 ± 0.46 | 1.17 ± 0.40 | NS |
| BMI, kg/m2 | 21.21 ± 3.51 | 20.71 ± 3.19 | NS |
| Weight gain, kg/week | 0.34 | 0.32 | NS |
| Medical factorsa | |||
| FGR-related risk factors | 103 (38.43) | 24 (17.27) | |
| Other risk factors | 83 (30.97) | 49 (35.25) | |
| Low risk factors | 82 (30.60) | 66 (47.48) | |
| Neonatal | |||
| Sex (male/female) | 121/147 | 75/64 | NS |
| Birth-weight ratio | 0.76 | 0.79 |
Data presented as n (%) prevalence, mean ± SD or median.
SGA, small for gestational age; FGR, fetal growth restriction; BMI, body mass index.
aFGR-related risk factors include patients with previous history of liveborn or stillborn SGA infants, and/or any chronic vascular disease, such as hypertension, diabetes mellitus, renal insufficiency, autoimmune disease, cyanotic cardiac disease, or antiphospholipid syndrome. Other risk factors include patients with risk factors unrelated to FGR, but requiring more regular healthcare visits. Low risk factors comprise patients without any risk factors.
NS, no statistically significant between-group differences (P > 0.05).
Rates and adjusted risk ratios for obstetric and neonatal outcomes in 407 pregnancies resulting in SGA infants divided into those with or without ultrasound suspicion of FGR.
| Variable | SGA+FGR( | SGA–FGR( | aRR (95% CI) | Statistical significance |
|---|---|---|---|---|
| Obstetric | ||||
| Iatrogenic delivery | 164/268 (61.19) | 57/139 (41.01) | 2.03 (1.31, 3.14) | |
| <37 weeks (preterm) | 46/164 (27.54) | 1/57 (1.75) | 10.61 (1.35, 83.62) | |
| Elective caesarean sectiona | 111/126 (88.10) | 19/43 (67.44) | 1.31 (1.05, 1.62) | |
| Iatrogenic delivery for fetal indications | 84/164 (51.22) | 25/57 (43.86) | 1.58 (0.79, 3.14) | NS |
| Neonatal | ||||
| Fetal death | 12/268 (4.48) | 4/139 (2.88) | NS | |
| Premature infants (<37 weeks) | 51/268 (19.03) | 1/139 (0.72) | 4.48 (1.29, 15.60) | |
| Resuscitation | 6/268 (2.24) | 8/139 (5.76) | 0.22 (0.06, 0.79) | |
| Apgar score <10 at 1 min | 48/268 (17.91) | 20/139 (14.39) | 1.50 (0.78, 2.90) | NS |
| Admission to NICU | 80/268 (29.85) | 20/139 (14.39) | 1.47 (0.80, 2.67) | NS |
Data presented as n (%) prevalence.
SGA, small for gestational age; FGR, fetal growth restriction; aRR, adjusted risk ratio; CI, confidence interval; NICU, neonatal intensive care unit.
aAs a proportion of total caesarean sections.
NS, no statistically significant risk between-group differences (P > 0.05).